Literature DB >> 28373537

Structure-metabolism relationships in human-AOX: Chemical insights from a large database of aza-aromatic and amide compounds.

Susan Lepri1, Martina Ceccarelli1, Nicolò Milani1, Sara Tortorella1, Andrea Cucco1, Aurora Valeri1, Laura Goracci1, Andreas Brink2, Gabriele Cruciani3.   

Abstract

Aldehyde oxidase (AOX) is a metabolic enzyme catalyzing the oxidation of aldehyde and aza-aromatic compounds and the hydrolysis of amides, moieties frequently shared by the majority of drugs. Despite its key role in human metabolism, to date only fragmentary information about the chemical features responsible for AOX susceptibility are reported and only "very local" structure-metabolism relationships based on a small number of similar compounds have been developed. This study reports a more comprehensive coverage of the chemical space of structures with a high risk of AOX phase I metabolism in humans. More than 270 compounds were studied to identify the site of metabolism and the metabolite(s). Both electronic [supported by density functional theory (DFT) calculations] and exposure effects were considered when rationalizing the structure-metabolism relationship.

Entities:  

Keywords:  aldehyde oxidase; amide hydrolysis; site of metabolism; structure–metabolism relationship; variously decorated heterocycles

Mesh:

Substances:

Year:  2017        PMID: 28373537      PMCID: PMC5402434          DOI: 10.1073/pnas.1618881114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  The role of drug metabolizing enzymes in clearance.

Authors:  Li Di
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-01-07       Impact factor: 4.481

2.  Exposition and reactivity optimization to predict sites of metabolism in chemicals.

Authors:  Gabriele Cruciani; Massimo Baroni; Paolo Benedetti; Laura Goracci; Cosimo Gianluca Fortuna
Journal:  Drug Discov Today Technol       Date:  2013

3.  Medicinal chemistry approaches to avoid aldehyde oxidase metabolism.

Authors:  David C Pryde; Thien-Duc Tran; Peter Jones; Jonathan Duckworth; Martin Howard; Iain Gardner; Ruth Hyland; Rob Webster; Tracey Wenham; Sharan Bagal; Kiyoyuki Omoto; Richard P Schneider; Jian Lin
Journal:  Bioorg Med Chem Lett       Date:  2012-03-03       Impact factor: 2.823

4.  Palladium-catalyzed cross-coupling reactions of diazine N-oxides with aryl chlorides, bromides, and iodides.

Authors:  Jean-Philippe Leclerc; Keith Fagnou
Journal:  Angew Chem Int Ed Engl       Date:  2006-11-27       Impact factor: 15.336

5.  A species difference in the presystemic metabolism of carbazeran in dog and man.

Authors:  B Kaye; J L Offerman; J L Reid; H L Elliott; W S Hillis
Journal:  Xenobiotica       Date:  1984-12       Impact factor: 1.908

Review 6.  Strategies for a comprehensive understanding of metabolism by aldehyde oxidase.

Authors:  James Matthew Hutzler; Ronald Scott Obach; Deepak Dalvie; Michael A Zientek
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-12-12       Impact factor: 4.481

7.  Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs.

Authors:  Raman Sharma; Timothy J Strelevitz; Hongying Gao; Alan J Clark; Klaas Schildknegt; R Scott Obach; Sharon L Ripp; Douglas K Spracklin; Larry M Tremaine; Alfin D N Vaz
Journal:  Drug Metab Dispos       Date:  2011-12-21       Impact factor: 3.922

8.  Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans.

Authors:  Takafumi Akabane; Kohichiro Tanaka; Megumi Irie; Shigeyuki Terashita; Toshio Teramura
Journal:  Xenobiotica       Date:  2011-03-09       Impact factor: 1.908

9.  Synthesis and activity of azaterphenyl diamidines against Trypanosoma brucei rhodesiense and Plasmodium falciparum.

Authors:  Laixing Hu; Reem K Arafa; Mohamed A Ismail; Alpa Patel; Manoj Munde; W David Wilson; Tanja Wenzler; Reto Brun; David W Boykin
Journal:  Bioorg Med Chem       Date:  2009-08-07       Impact factor: 3.641

10.  Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles.

Authors:  Lukás Palek; Jaroslav Dvorák; Michaela Svobodová; Vladimír Buchta; Josef Jampílek; Martin Dolezal
Journal:  Arch Pharm (Weinheim)       Date:  2008-01       Impact factor: 3.751

View more
  5 in total

Review 1.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

Review 2.  Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes.

Authors:  Mineko Terao; Enrico Garattini; Maria João Romão; Silke Leimkühler
Journal:  J Biol Chem       Date:  2020-03-06       Impact factor: 5.157

3.  Ready access to 7,8-dihydroindolo[2,3-d][1]benzazepine-6(5H)-one scaffold and analogues via early-stage Fischer ring-closure reaction.

Authors:  Irina Kuznetcova; Felix Bacher; Daniel Vegh; Hsiang-Yu Chuang; Vladimir B Arion
Journal:  Beilstein J Org Chem       Date:  2022-01-26       Impact factor: 2.883

4.  Direct comparison of the four aldehyde oxidase enzymes present in mouse gives insight into their substrate specificities.

Authors:  Gökhan Kücükgöze; Silke Leimkühler
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

5.  Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications.

Authors:  Laura Goracci; Jenny Desantis; Aurora Valeri; Beatrice Castellani; Michela Eleuteri; Gabriele Cruciani
Journal:  J Med Chem       Date:  2020-10-07       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.